Wangmao Ge
68Patents
10h-index
12Co-inventors
71Inventor score
Filing activity: Aug 28, 2001 → Oct 21, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7361338B2 | Methods to inhibit growth of prostate cancer cells | Chemistry; Metallurgy | 33 | Expired |
| US7641905B2 | Methods of inducing an immune response | Human Necessities | 22 | Expired |
| US7628989B2 | Methods of inducing an immune response | Human Necessities | 22 | Expired |
| US7622564B2 | Prostate stem cell antigen (PSCA) variants and subsequences thereof | Emerging Cross-Sectional Technologies | 17 | Active |
| US7884179B2 | Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer | Chemistry; Metallurgy | 16 | Active |
| US7968090B2 | Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 15 | Active |
| US7226594B2 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7244827B2 | Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer | Chemistry; Metallurgy | 12 | Expired |
| US7622569B2 | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer | Chemistry; Metallurgy | 11 | Active |
| US7667018B2 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 10 | Active |
| US7749746B2 | Nucleic acid encoding 238P1B2 useful in detecting cancer | Chemistry; Metallurgy | 9 | Active |
| US8426571B2 | Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 9 | Active |
| US8124741B2 | Antibodies to tumor associated proteins | Chemistry; Metallurgy | 7 | Active |
| US7449548B2 | Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7115727B2 | Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7553814B2 | 238P1B2 protein | Chemistry; Metallurgy | 3 | Active |
| US7592149B2 | Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 3 | Active |
| US7358353B2 | Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7135549B1 | Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7563444B2 | Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer | Human Necessities | 2 | Expired |
| US7217799B2 | Antibodies that recognize the 85P1B3 protein useful in treatment and detection of cancer | Chemistry; Metallurgy | 2 | Expired |
| US7642342B2 | Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 1 | Active |
| US7488479B2 | Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7659377B2 | Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer | Emerging Cross-Sectional Technologies | 1 | Active |
| US7842458B2 | Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer | Physics | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.